QUEST PHARMACEUTICAL SERVICES TAIWA

Company Introduction: QUEST PHARMACEUTICAL SERVICES TAIWA

QUEST PHARMACEUTICAL SERVICES TAIWA is the Taiwan branch of Quest Pharmaceutical Services (QPS), a global Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO).

QPS offers a comprehensive suite of services throughout the entire drug development lifecycle, ranging from discovery and preclinical research to clinical trials, bioanalysis, and commercial manufacturing. They support pharmaceutical, biotechnology, and medical device companies in advancing their product pipelines across various therapeutic areas.

Regarding whether it is a factory or a trading company:

QUEST PHARMACEUTICAL SERVICES TAIWA is primarily a service provider. As a Contract Development and Manufacturing Organization (CDMO), it operates facilities dedicated to the development and manufacturing of pharmaceutical products for its clients. Therefore, it functions as a specialized manufacturing entity (a factory) within the context of contract manufacturing. It is not a trading company.

Quest Pharmaceutical Services Taiwan (QPS Taiwan) does not manufacture or sell pharmaceutical drugs or consumer products. As a Contract Research Organization (CRO), the company provides specialized research and development services to the pharmaceutical and biotechnology industries.

Their service offerings include:

1. Clinical Research Services

Phase I to Phase IV clinical trial management, monitoring, and project management.

2. Bioanalysis

Pharmacokinetic (PK) and Pharmacodynamic (PD) analysis, biomarker analysis, and immunogenicity testing using LC-MS/MS and ligand-binding assays.

3. Drug Metabolism and Pharmacokinetics (DMPK)

In vitro and in vivo studies to evaluate drug absorption, distribution, metabolism, and excretion.

4. Toxicology

Preclinical safety and toxicity studies to support regulatory filings.

5. Translational Medicine

Early-stage research services to bridge the gap between discovery and clinical development.

6. Regulatory Affairs

Consulting and support for regulatory submissions and interactions with health authorities.